Evaluating the toxic and beneficial effects of jering beans (Archidendron jiringa) in normal and diabetic rats

Journal of the Science of Food and Agriculture

Volumn 91, Issue 14, 2011, Pages 2697-2706

  Shukri, Radhiah ^a   Mohamed, Suhaila ^a   Mustapha, Noordin Mohamed ^a   Hamid, Azizah Abdul ^a  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

Author keywords

Diabetes; Organs; Rats; Toxicity; Unusual amino acid

Indexed keywords

CYSTEINE; DJENKOLIC ACID; DRUG DERIVATIVE;

ANIMAL; ARTICLE; BLOOD; BODY WEIGHT; CHEMISTRY; DIABETIC RETINOPATHY; DIET; DIET THERAPY; ETHNOLOGY; FABACEAE; HEART MUSCLE; HYPERGLYCEMIA; HYPERTROPHY; KIDNEY; LIVER; MALAYSIA; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PANCREAS; PATHOLOGY; PLANT SEED; RANDOMIZATION; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; BODY WEIGHT; CYSTEINE; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; DIET; FABACEAE; HYPERGLYCEMIA; HYPERTROPHY; KIDNEY; LIVER; MALAYSIA; MALE; MYOCARDIUM; OXIDATIVE STRESS; PANCREAS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; SEEDS;

ARCHIDENDRON; RATTUS;

EID: 80053899674     PISSN: 00225142     EISSN: 10970010     Source Type: Journal    
DOI: 10.1002/jsfa.4516     Document Type: Article

References (27)

1. Thevathasan OI, Hypoglycaemia induced in fasted cats by aqueous extracts of Pithecellobium jiringa. Med J Malaya 26: 217-219 (1972).
2. van Veen AG and Hyman AJ, On the toxic component of the djenkol bean. Geneesk Tijdschr Nederl Indie 73: 991 (1933).
3. Tee ES, Noor MI, Azudin MN and Idris K, Nutrient Composition of Malaysian Foods (4th edn). Institute for Medical Research Malaysia, Kuala Lumpur, pp. 68-69 (1997).
4. Shukri R, Mohamed S and Mustapha NM, Cloves protect the heart, liver and lens of diabetic rats. Food Chem 122: 1116-1121 (2010).
5. Gupta RK, Kesari AN, Diwakar S, Tyagi A, Tandon V, Chandra R, et al, In vivo evaluation of anti-oxidant and anti-lipidimic potential of Annona squamosa aqueous extract in Type 2 diabetic models. J Ethnopharmacol 118: 21-25 (2008).
6. Gilman AG, Rall TW, Nies AS and Tayer P, in The Pharmacological Basis of Therapeutics (8th edn), ed. by Goodman LS and Gilman AG. Pergamon Press, New York, pp. 1317-1322, 1463-1495 (1990).
7. Scheicher ED, Wagner E and Nerlich AG, Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues and aging. J Clin Invest 99: 457-468 (1997).
8. Williams SB, Goldfine AB, Timimi FK, Ting HH, Roddy MA and Simonson DC, Acute hyperglycaemia attenuates endothelium-dependent vasodilatation in humans in vivo. Circulation 97: 1695-1701 (1998).
9. Rosen P, Nawroth PP, King G, Moller W, Tritschler HJ and Packer L, The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society. Diabetes Metab Res Rev 17: 189-212 (2001).
10. Finkel T and Holbrook NJ, Oxidants, oxidative stress and the biology of ageing. Nature 408: 239-247 (2000).
11. Singal PK, Dhalla AK, Hill AK and Thomas AP, Endogenous antioxidant changes in the myocardium in response to acute and chronic stress condition. Mol Cell Biochem 129: 179-186 (1993).
12. 2-removing enzyme in human erythrocytes. Blood 90: 4973-4978 (1997).
13. Dai S and McNeill JH, Myocardial performance of STZ-diabetic DOCA-hypertensive rats. Am J Physiol 263: H1798-H1805 (1992).
14. Shafrir E and Sima AAF, Diabetic animals for research into the complications: a general overview, in Chronic Complications in Diabetes, ed. by Sima AAF. Harwood, Amsterdam, pp. 1-42 (2000).
15. Steffes MW, Osterby R, Chavers B and Mauer SM, Mesangial expansion as a central mechanism for loss of kidney functions in diabetic patients. Diabetes 38: 1077-1081 (1984).
16. Kaneko JJ, Clinical Biochemistry of Domestic Animals (4th edn). Academic Press, San Diego, CA, pp. 892-897 (1989).
17. Kedziora-Kornatowska K, Defense mechanisms in streptozotocin-induced diabetes in rat. Clin Chim Acta 322: 105-112 (2002).
18. Sharma K and Ziyadeh FN, Biochemical events and cytokine interactions linking glucose metabolism to the development of diabetic nephropathy. Semin Nephrol 17: 80-92 (1997).
19. Duncan JR and Prasse KW, Veterinary Laboratory Medicine: Clinical Pathology (2nd edn). Wiley-Blackwell, Chichester, pp. 167-169 (1986).
20. Levinthal GN and Tavill AS, Liver disease and diabetes mellitus. Clin Diabetes 17: 1-21 (1999).
21. Bloodworth JMB and Hamwi GJ, Histopathologic lesion associated with sulfonylurea administration. Diabetes 10: 90-99. (1961).
22. Dringen R, Metabolism and functions of glutathione in brain. Prog Neurobiol 62: 649-671 (2000).
23. Aliciguzel Y, Ozen I, Aslan M and Karayalcin U, Activities of xanthine oxidoreductase and antioxidant enzymes in different tissues of diabetic rats. J Lab Clin Med. 142: 172-177 (2003).
24. Friesen NT, Büchau AS, Schott-Ohly P, Lgssiar A and Gleichmann H, Generation of hydrogen peroxide and failure of antioxidative responses in pancreatic islets of male C57BL/6 mice are associated with diabetes induced by multiple low doses of streptozotocin. Diabetologia 47: 676-685 (2004).
25. Gumieniczek A, Hopka3a H, Wójtowicz Z and Wysocka M, Changes in antioxidant status of lung tissue in experimental diabetes in rabbits. Clin Biochem 35: 147-149 (2002).
26. Kyselova Z, Stefek M and Bauer V, Pharmacological prevention of diabetic cataract. J Diabetes Complications 18: 129-140 (2004).
27. Rizkalla SW, Bellisle F and Slama G, Health benefits of low glycaemic index foods, such as pulses, in diabetic patients and healthy individuals. Br J Nutr 88: 255-262 (2002).